Patents by Inventor Birkir SVEINSSON

Birkir SVEINSSON has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF TREATING INFLAMMATORY SKIN DISORDERS
    Publication number: 20230181693
    Abstract: A method for treating, remedying, or preventing inflammatory skin disorders by administering a therapeutically effective dose of at least one an antagonist of a calcitonin gene-related peptide receptor in a pharmaceutically acceptable formulation. The method for treating, remedying, or preventing an inflammatory skin disorder by administering topically and to the prepsoriatic rim a therapeutically effective dose of at least one an antagonist of a calcitonin gene-related peptide receptor in a pharmaceutically acceptable formulation.
    Type: Application
    Filed: October 20, 2022
    Publication date: June 15, 2023
    Inventor: Birkir SVEINSSON
  • Methods of treating inflammatory skin disorders
    Patent number: 11517612
    Abstract: A method for treating, remedying, or preventing inflammatory skin disorders by administering a therapeutically effective dose of at least one an antagonist of a calcitonin gene-related peptide receptor in a pharmaceutically acceptable formulation. The method for treating, remedying, or preventing an inflammatory skin disorder by administering topically and to the pre-psoriatic rim a therapeutically effective dose of at least one an antagonist of a calcitonin gene-related peptide receptor in a pharmaceutically acceptable formulation.
    Type: Grant
    Filed: May 30, 2020
    Date of Patent: December 6, 2022
    Assignee: NEPSONE EHF
    Inventor: Birkir Sveinsson
  • Methods of treating inflammatory skin disorders
    Patent number: 11433119
    Abstract: A method for treating, remedying, or preventing inflammatory skin disorders by administering a therapeutically effective dose of at least one an antagonist of a calcitonin gene-related peptide receptor in a pharmaceutically acceptable formulation. The method for treating, remedying, or preventing an inflammatory skin disorder by administering topically and to the pre-psoriatic rim a therapeutically effective dose of at least one an antagonist of a calcitonin gene-related peptide receptor in a pharmaceutically acceptable formulation.
    Type: Grant
    Filed: May 30, 2020
    Date of Patent: September 6, 2022
    Assignee: NEPSONE EHF
    Inventor: Birkir Sveinsson
  • Methods of treating inflammatory skin disorders
    Patent number: 11266718
    Abstract: A method for treating, remedying, or preventing inflammatory skin disorders by administering a therapeutically effective dose of at least one an antagonist of a calcitonin gene-related peptide receptor in a pharmaceutically acceptable formulation. The method for treating, remedying, or preventing an inflammatory skin disorder by administering topically and to the pre-psoriatic rim a therapeutically effective dose of at least one an antagonist of a calcitonin gene-related peptide receptor in a pharmaceutically acceptable formulation.
    Type: Grant
    Filed: May 30, 2020
    Date of Patent: March 8, 2022
    Assignee: NEPSONE EHF
    Inventor: Birkir Sveinsson
  • METHODS OF TREATING INFLAMMATORY SKIN DISORDERS
    Publication number: 20200338170
    Abstract: A method for treating, remedying, or preventing inflammatory skin disorders by administering a therapeutically effective dose of at least one an antagonist of a calcitonin gene-related peptide receptor in a pharmaceutically acceptable formulation. The method for treating, remedying, or preventing an inflammatory skin disorder by administering topically and to the pre-psoriatic rim a therapeutically effective dose of at least one an antagonist of a calcitonin gene-related peptide receptor in a pharmaceutically acceptable formulation.
    Type: Application
    Filed: May 30, 2020
    Publication date: October 29, 2020
    Inventor: Birkir SVEINSSON
  • METHODS OF TREATING INFLAMMATORY SKIN DISORDERS
    Publication number: 20200338168
    Abstract: A method for treating, remedying, or preventing inflammatory skin disorders by administering a therapeutically effective dose of at least one an antagonist of a calcitonin gene-related peptide receptor in a pharmaceutically acceptable formulation. The method for treating, remedying, or preventing an inflammatory skin disorder by administering topically and to the pre-psoriatic rim a therapeutically effective dose of at least one an antagonist of a calcitonin gene-related peptide receptor in a pharmaceutically acceptable formulation.
    Type: Application
    Filed: May 30, 2020
    Publication date: October 29, 2020
    Inventor: Birkir SVEINSSON
  • METHODS OF TREATING INFLAMMATORY SKIN DISORDERS
    Publication number: 20200338169
    Abstract: A method for treating, remedying, or preventing inflammatory skin disorders by administering a therapeutically effective dose of at least one an antagonist of a calcitonin gene-related peptide receptor in a pharmaceutically acceptable formulation. The method for treating, remedying, or preventing an inflammatory skin disorder by administering topically and to the pre-psoriatic rim a therapeutically effective dose of at least one an antagonist of a calcitonin gene-related peptide receptor in a pharmaceutically acceptable formulation.
    Type: Application
    Filed: May 30, 2020
    Publication date: October 29, 2020
    Inventor: Birkir SVEINSSON
  • Use of CGRP antagonist compounds for treatment of psoriasis
    Patent number: 10668132
    Abstract: A method for treating, remedying, or preventing psoriasis by administering a therapeutically effective dose of at least one CGRP antagonist compound in a pharmaceutically acceptable formulation. The method for treating, remedying, or preventing psoriasis by administering topically and to the pre-psoriatic rim a therapeutically effective dose of at least one CGRP antagonist compound in a pharmaceutically acceptable formulation.
    Type: Grant
    Filed: November 18, 2016
    Date of Patent: June 2, 2020
    Assignee: NEPSONE EHF
    Inventor: Birkir Sveinsson
  • USE OF CGRP ANTAGONIST COMPOUNDS FOR TREATMENT OF PSORIASIS
    Publication number: 20170065681
    Abstract: A method for treating, remedying, or preventing psoriasis by administering a therapeutically effective dose of at least one CGRP antagonist compound in a pharmaceutically acceptable formulation. The method for treating, remedying, or preventing psoriasis by administering topically and to the pre-psoriatic rim a therapeutically effective dose of at least one CGRP antagonist compound in a pharmaceutically acceptable formulation.
    Type: Application
    Filed: November 18, 2016
    Publication date: March 9, 2017
    Inventor: Birkir Sveinsson
  • Use of CGRP antagonist compounds for treatment of psoriasis
    Patent number: 9585940
    Abstract: The invention provides methods and compositions for treating, preventing and/or remedying psoriasis, based on compounds that have a calcitonin-related gene peptide (CGRP) antagonistic effect. Methods are also disclosed for identifying compounds with CGRP antagonist activity which thereby are suitable candidate compounds for treating psoriasis.
    Type: Grant
    Filed: August 16, 2013
    Date of Patent: March 7, 2017
    Assignee: Birkir Sveinsson
    Inventor: Birkir Sveinsson
  • USE OF CGRP ANTAGONIST COMPOUNDS FOR TREATMENT OF PSORIASIS
    Publication number: 20140220030
    Abstract: The invention provides methods and compositions for treating, preventing and/or remedying psoriasis, based on compounds that have a calcitonin-related gene peptide (CGRP) antagonistic effect. Methods are also disclosed for identifying compounds with CGRP antagonist activity which thereby are suitable candidate compounds for treating psoriasis.
    Type: Application
    Filed: August 16, 2013
    Publication date: August 7, 2014
    Inventor: Birkir Sveinsson
  • USE OF CGRP ANTAGONIST COMPOUNDS FOR TREATMENT OF PSORIASIS
    Publication number: 20110150890
    Abstract: The invention provides methods and compositions for treating, preventing and/or remedying psoriasis, based on compounds that have a calcitonin-related gene peptide (CGRP) antagonistic effect. Methods are also disclosed for identifying compounds with CGRP antagonist activity which thereby are suitable candidate compounds for treating psoriasis.
    Type: Application
    Filed: March 2, 2011
    Publication date: June 23, 2011
    Inventor: Birkir SVEINSSON